Supernus Pharmaceuticals in Rockville filed to raise $100 million in an IPO. The company is working on drugs to treat central nervous system disorders, including epilepsy and attention deficit disorder. [From WaPo]
- Subscribe/Follow Us:
A look at technology in the DC area [Create:Read:Update:Delete]